• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于监测、流行病学和最终结果(SEER)数据库的N0M0期肝细胞癌肝切除术后预后的真实世界研究

A Real-World Study of Prognosis of N0M0 Hepatocellular Carcinoma with Hepatic Resection Based on SEER Database.

作者信息

Zhu Guangxi, Wang Wensheng, Liu Qin, Chen Dongfeng, Wen Liangzhi

机构信息

Department of Gastroenterology, Daping Hospital, Army Medical University, Chongqing, China.

出版信息

Gastroenterol Res Pract. 2020 Apr 1;2020:2357840. doi: 10.1155/2020/2357840. eCollection 2020.

DOI:10.1155/2020/2357840
PMID:32328093
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7152960/
Abstract

AIM

To develop and validate a simple-to-use nomogram for prediction of 3-/5-year survival in patients with N0M0 hepatocellular carcinoma after curative liver resection. . Patients diagnosed HCC with hepatic resection in the Surveillance, Epidemiology, and End Results (SEER) database were included to identify prognostic factors of overall survival. Multivariate Cox regression were used to create a nomogram.

RESULTS

We identified 4856 HCC with hepatic resection from the SEER database. A nomogram to predict long-term survival with a C-index 0.667 (95% CI, 0.653 to 0.681) is more efficient than TNM staging with a lower C-index 0.613 (95% CI, 0.597 to 0.629). The C-index was confirmed to be 0.663 (95% CI, 0.640 to 0.686) through validation, suggesting a good discrimination and a good prediction capability.

CONCLUSIONS

The nomogram is a simple and effective screening tool for assessing the prognosis of HCC with hepatic resection and assists with the planning of individual postoperative surveillance protocols.

摘要

目的

开发并验证一种易于使用的列线图,用于预测根治性肝切除术后N0M0肝细胞癌患者的3/5年生存率。纳入监测、流行病学和最终结果(SEER)数据库中诊断为肝癌并接受肝切除的患者,以确定总生存的预后因素。采用多因素Cox回归创建列线图。

结果

我们从SEER数据库中识别出4856例接受肝切除的肝癌患者。用于预测长期生存的列线图C指数为0.667(95%CI,0.653至0.681),比C指数较低的TNM分期(0.613,95%CI,0.597至0.629)更有效。通过验证,C指数被确认为0.663(95%CI,0.640至0.686),表明具有良好的区分度和预测能力。

结论

该列线图是评估肝癌肝切除预后的一种简单有效的筛查工具,有助于制定个体化的术后监测方案。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/644b/7152960/b04d98e6b925/GRP2020-2357840.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/644b/7152960/6f4a30008c3f/GRP2020-2357840.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/644b/7152960/5de48e48e85e/GRP2020-2357840.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/644b/7152960/013466b89e0f/GRP2020-2357840.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/644b/7152960/35e24011cbeb/GRP2020-2357840.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/644b/7152960/c056fd8b1fa6/GRP2020-2357840.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/644b/7152960/b04d98e6b925/GRP2020-2357840.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/644b/7152960/6f4a30008c3f/GRP2020-2357840.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/644b/7152960/5de48e48e85e/GRP2020-2357840.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/644b/7152960/013466b89e0f/GRP2020-2357840.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/644b/7152960/35e24011cbeb/GRP2020-2357840.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/644b/7152960/c056fd8b1fa6/GRP2020-2357840.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/644b/7152960/b04d98e6b925/GRP2020-2357840.006.jpg

相似文献

1
A Real-World Study of Prognosis of N0M0 Hepatocellular Carcinoma with Hepatic Resection Based on SEER Database.基于监测、流行病学和最终结果(SEER)数据库的N0M0期肝细胞癌肝切除术后预后的真实世界研究
Gastroenterol Res Pract. 2020 Apr 1;2020:2357840. doi: 10.1155/2020/2357840. eCollection 2020.
2
Development and external validation of a nomogram predicting overall survival after curative resection of colon cancer.开发并验证用于预测结肠癌根治性切除术后总生存的列线图
J Int Med Res. 2021 May;49(5):3000605211015023. doi: 10.1177/03000605211015023.
3
A Nomogram to Predict Individual Survival of Patients with Liver-Limited Metastases from Gastroenteropancreatic Neuroendocrine Neoplasms: A US Population-Based Cohort Analysis and Chinese Multicenter Cohort Validation Study.基于美国人群队列分析和中国多中心队列验证研究的胃胰神经内分泌肿瘤肝转移患者个体生存预测列线图
Neuroendocrinology. 2022;112(3):263-275. doi: 10.1159/000516812. Epub 2021 Apr 26.
4
Establishment of a Nomogram by Integrating Molecular Markers and Tumor-Node-Metastasis Staging System for Predicting the Prognosis of Hepatocellular Carcinoma.建立一个列线图,通过整合分子标志物和肿瘤-淋巴结-转移分期系统来预测肝细胞癌的预后。
Dig Surg. 2019;36(5):426-432. doi: 10.1159/000494219. Epub 2018 Nov 27.
5
Nomogram predicting survival of hepatocellular carcinoma with portal vein tumour thrombus after curative resection.预测根治性切除术后伴有门静脉癌栓的肝细胞癌患者生存情况的列线图
ANZ J Surg. 2019 Jan;89(1-2):E20-E25. doi: 10.1111/ans.14708. Epub 2018 Aug 17.
6
Development and Validation of a Nomogram-Based Prognostic Evaluation Model for Sarcomatoid Hepatocellular Carcinoma.肉瘤样肝细胞癌列线图预后评估模型的建立与验证。
Adv Ther. 2020 Jul;37(7):3185-3205. doi: 10.1007/s12325-020-01357-3. Epub 2020 May 20.
7
Prognostic Nomograms Stratify Survival of Patients with Hepatocellular Carcinoma Without Portal Vein Tumor Thrombosis After Curative Resection.预后列线图对根治性切除术后无门静脉肿瘤血栓形成的肝细胞癌患者的生存情况进行分层。
Oncologist. 2017 May;22(5):561-569. doi: 10.1634/theoncologist.2016-0231. Epub 2017 Apr 24.
8
A novel prognostic nomogram based on microvascular invasion and hematological biomarkers to predict survival outcome for hepatocellular carcinoma patients.基于微血管侵犯和血液学生物标志物的新型预后列线图预测肝细胞癌患者的生存结局。
Surg Oncol. 2020 Jun;33:51-57. doi: 10.1016/j.suronc.2020.01.006. Epub 2020 Jan 11.
9
Development and validation of a nomogram for predicting cancer-specific survival of surgical resected stage I-II adenosquamous carcinoma of the lung.建立并验证一个列线图模型,以预测手术切除的 I-II 期肺腺鳞癌患者的癌症特异性生存。
J Surg Oncol. 2020 May;121(6):1027-1035. doi: 10.1002/jso.25858. Epub 2020 Feb 5.
10
Development and Validation of an Individualized Nomogram for Predicting Survival in Patients with Esophageal Carcinoma after Resection.预测食管癌切除术后患者生存的个体化列线图的开发与验证
J Cancer. 2020 Apr 6;11(14):4023-4029. doi: 10.7150/jca.40767. eCollection 2020.

引用本文的文献

1
Development and validation of a nomogram to predict cancer-specific survival of patients with large hepatocellular carcinoma accepting surgical resection: a real-world analysis based on the SEER database.预测接受手术切除的大肝细胞癌患者癌症特异性生存的列线图的开发与验证:基于监测、流行病学和最终结果(SEER)数据库的真实世界分析
J Gastrointest Oncol. 2024 Aug 31;15(4):1657-1673. doi: 10.21037/jgo-24-285. Epub 2024 Aug 20.
2
Development and validation of web-based prognostic nomograms for massive hepatocellular carcinoma (≥10 cm): A retrospective study based on the SEER database.基于 SEER 数据库的回顾性研究:开发和验证用于巨块型肝细胞癌(≥10cm)的基于网络的预后列线图。
Cancer Med. 2023 Jun;12(12):13167-13181. doi: 10.1002/cam4.6003. Epub 2023 Apr 27.
3

本文引用的文献

1
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
2
Critical evaluation of the American Joint Commission on Cancer (AJCC) 8th edition staging system for patients with Hepatocellular Carcinoma (HCC): A Surveillance, Epidemiology, End Results (SEER) analysis.对美国癌症联合委员会(AJCC)第8版肝细胞癌(HCC)患者分期系统的批判性评估:一项监测、流行病学与最终结果(SEER)分析。
J Surg Oncol. 2018 Mar;117(4):644-650. doi: 10.1002/jso.24908. Epub 2017 Nov 11.
3
Real-World Study: A Powerful Tool for Malignant Tumor Research in General Surgery.真实世界研究:普通外科恶性肿瘤研究的有力工具。
Cancers (Basel). 2022 Nov 2;14(21):5408. doi: 10.3390/cancers14215408.
4
A Ferroptosis-Related LncRNA Signature Associated with Prognosis, Tumor Immune Environment, and Genome Instability in Hepatocellular Carcinoma.一个与肝细胞癌预后、肿瘤免疫微环境和基因组不稳定性相关的铁死亡相关长非编码 RNA 特征。
Comput Math Methods Med. 2022 Aug 18;2022:6284540. doi: 10.1155/2022/6284540. eCollection 2022.
Proton beam therapy for hepatocellular carcinoma.
肝细胞癌的质子束治疗
Expert Rev Anticancer Ther. 2017 Oct;17(10):911-924. doi: 10.1080/14737140.2017.1368392. Epub 2017 Aug 21.
4
The prognostic utility of baseline alpha-fetoprotein for hepatocellular carcinoma patients.基线甲胎蛋白对肝细胞癌患者的预后评估价值
J Surg Oncol. 2017 Dec;116(7):831-840. doi: 10.1002/jso.24742. Epub 2017 Jul 25.
5
Current Standard and Future Perspectives in Non-Surgical Therapy for Hepatocellular Carcinoma.肝细胞癌非手术治疗的当前标准与未来展望
Digestion. 2017;96(1):1-4. doi: 10.1159/000464282. Epub 2017 Jun 13.
6
The Surveillance, Epidemiology, and End Results (SEER) Program and Pathology: Toward Strengthening the Critical Relationship.监测、流行病学与最终结果(SEER)计划与病理学:致力于强化关键关系
Am J Surg Pathol. 2016 Dec;40(12):e94-e102. doi: 10.1097/PAS.0000000000000749.
7
Cancer statistics in China, 2015.《中国癌症统计数据 2015》
CA Cancer J Clin. 2016 Mar-Apr;66(2):115-32. doi: 10.3322/caac.21338. Epub 2016 Jan 25.
8
Nomograms Predicting Progression-Free Survival, Overall Survival, and Pelvic Recurrence in Locally Advanced Cervical Cancer Developed From an Analysis of Identifiable Prognostic Factors in Patients From NRG Oncology/Gynecologic Oncology Group Randomized Trials of Chemoradiotherapy.基于NRG肿瘤学/妇科肿瘤学组同步放化疗随机试验中患者可识别的预后因素分析开发的列线图,用于预测局部晚期宫颈癌的无进展生存期、总生存期和盆腔复发。
J Clin Oncol. 2015 Jul 1;33(19):2136-42. doi: 10.1200/JCO.2014.57.7122. Epub 2015 Mar 2.
9
Development and validation of a nomogram for predicting survival in patients with resected non-small-cell lung cancer.建立并验证一个列线图模型预测可切除非小细胞肺癌患者的生存情况。
J Clin Oncol. 2015 Mar 10;33(8):861-9. doi: 10.1200/JCO.2014.56.6661. Epub 2015 Jan 26.
10
Tumour size and differentiation predict survival after liver resection for hepatocellular carcinoma arising from non-cirrhotic and non-fibrotic liver: a case-controlled study.肿瘤大小和分化程度可预测非肝硬化、非纤维化肝脏来源的肝细胞癌肝切除术后的生存:一项病例对照研究。
Int J Surg. 2013;11(10):1078-82. doi: 10.1016/j.ijsu.2013.10.001. Epub 2013 Oct 12.